Efforts to update the medical kits required on U.S. commercial flights have encountered unexpected resistance following a recent proposal by the Federal Aviation Administration (FAA) that would loosen current mandates for onboard emergency supplies.
Kim Blumenthal, an immunologist trained at Yale, became acutely aware of the limitations of airline medical kits after responding to three inflight medical emergencies over the past five years, including severe allergic reactions in children. She found the kits outdated, with basic equipment such as plastic stethoscopes, disposable blood pressure cuffs, and epinephrine delivered in glass ampoules requiring manual dosing—methods she described as “archaic” and potentially inadequate during urgent situations.
Current FAA regulations require most U.S. airlines to carry emergency medical kits stocked with a fixed list of 64 items, including specific drugs and diagnostic tools aimed at treating conditions like cardiac arrest and allergic reactions. These kits are compulsory, and an incomplete kit can prevent a flight from departing.
However, in August, the FAA proposed replacing this mandatory list with a “performance-based requirement” that would allow airlines discretion over kit contents, provided they are equipped to treat nine specified medical emergencies. Notably, this would eliminate the requirement to carry particular drugs, including epinephrine, widely considered essential for treating life-threatening allergic reactions. The FAA defended the move as an effort to “increase flexibility” for airlines and reduce costs.
The proposal has drawn swift criticism from medical professionals and advocacy groups. Jenna Riemenschneider of the Asthma and Allergy Foundation of America called the plan “unacceptable,” emphasizing concerns that safety standards appear to have been lowered rather than improved. Former American College of Allergy, Asthma and Immunology president J. Allen Meadows also expressed disappointment, noting the FAA largely overlooked recommendations from its own expert advisory panel convened under a 2024 law mandating medical kit updates.
That panel, led by the Aerospace Medical Association, submitted a report in 2025 recommending enhancements including digital thermometers, automatic blood pressure cuffs, pulse oximeters, drugs for convulsions and psychosis, and—critically—epinephrine auto-injectors and naloxone nasal spray for opioid overdoses. None of these specific additions appear in the FAA’s latest proposal, which instead presents items as non-mandatory options. Paulo Alves, the panel co-chair, acknowledged initial surprise but later expressed cautious support, viewing the FAA’s approach as an evolutionary step allowing medical kits to adapt without protracted regulatory delays.
The American Medical Association and the National Association of EMS Physicians have likewise raised concerns, urging that at least minimum standards based on expert advice be maintained to ensure public safety. Senate Minority Leader Chuck Schumer and Senator Tammy Duckworth recently warned U.S. airlines that the proposed changes could undermine passenger safety and trust by creating “ambiguity, subjectivity and opacity” around kit contents.
Airlines have generally declined to comment on the FAA’s ongoing review, which has attracted over 1,500 public submissions and remains open for feedback until early October. The FAA is required to consider these responses before finalizing any rule changes.
Medical emergencies during flights are relatively common. A 2025 study found one in every 212 flights involved incidents serious enough to necessitate crew consultation with ground medical teams, with emergency kits used in about a quarter of these cases. Aircraft diversions due to health crises occur in approximately 1.7% of these situations, mostly related to cardiac or neurological issues.
As the FAA weighs the next steps, advocates like Blumenthal worry that cost-cutting measures may lead airlines to equip cabins with the cheapest rather than the most effective tools. “I worry that they’re going to just use the cheapest things, not the easiest or best,” she said, highlighting the challenge of balancing flexibility with the imperative of passenger safety at 30,000 feet.